Skip to main content
Clinical Trials/NCT06334237
NCT06334237
Recruiting
Not Applicable

Exploring the Psychosomatic Factors Influencing and Moderating the Efficacy of Holistic Care and Personalized Treatment for Migraine Patients: A Prospective Longitudinal Observational Study

Changhua Christian Hospital1 site in 1 country120 target enrollmentApril 18, 2024
ConditionsMigraine

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Migraine
Sponsor
Changhua Christian Hospital
Enrollment
120
Locations
1
Primary Endpoint
Effectiveness of acute medication
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This research project aims at exploring the psychosomatic factors that influence and moderate the efficacy of holistic care and personalized treatment for migraine patients. It is a prospective longitudinal observational study. The project's goal is to understand how physical, psychological, spiritual, and social factors affect the care and treatment outcomes for migraineurs. The study will include participants aged 18 to 65, who meet the International Headache Society's criteria for migraines. It will utilize a range of methodologies including questionnaires, interviews, and medical records to collect data on various factors like lifestyle, psychological state, and social support. The project will assess the effectiveness of treatments, compliance, and other outcomes such as emotional and sleep conditions.

Detailed Description

In this study, participants will be recruited through clinics. All the participants will be asked to keep a migraine diary for the duration of three months. In addition to that, the participants will fill out questionnaires that measures depression, anxiety, well-being and migraine related disability. This study does not intervene with the routine clinical care. The investigators merely observe through participant's diary and other patient reports to find out about how psychological and social factors might lead to different clinical outcomes.

Registry
clinicaltrials.gov
Start Date
April 18, 2024
End Date
February 21, 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • individuals aged between 18 and 65 who meet the International Headache Society's criteria for migraines

Exclusion Criteria

  • incapacitate such as dementia or cognitive deficiency
  • illiterate, or could not sign informed consents
  • severe disorder or co-morbidities that the doctors advice against participation

Outcomes

Primary Outcomes

Effectiveness of acute medication

Time Frame: 3 months

The effectiveness of acute medication will be assessed by a 4-point scale measuring the degree of pain relief after medication administration, recorded in the migraine diary: 1. No effect at all 2. Minimal effect, headache slightly improved 3. Good effect, headache significantly improved 4. Very effective, pain completely resolved

Migraine attack duration

Time Frame: 3 months

The duration of each migraine attack will be recorded in the migraine diary, measured in hours.

Migraine attack frequency

Time Frame: 3 months

The frequency of migraine attacks will be assessed by the number of days with migraine attacks recorded in the migraine diary.

Migraine attack intensity

Time Frame: 3 months

The intensity of migraine attacks will be assessed by the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst pain imaginable). Higher scores indicate greater pain intensity.

Secondary Outcomes

  • depression(3 months)
  • anxiety(3 months)
  • well-being(3 months)
  • Compliance rate of migraine diary(3 months)
  • Pain Resilience(3 months)
  • Compliance rate of lifestyle modification(3 months)

Study Sites (1)

Loading locations...

Similar Trials